ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

Cancer Meetings Listed

October 24, 1997

Parkinson Heads Oncology At Amgen

May 2, 2003

NCI, EORTC Offer Support For Russian Cancer Researchers

April 14, 1995

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

September 8, 1978

Selumetinib Displays Positive Results, 60% with Stable Disease

April 29, 2011